Search for Biosample

Included Properties

Data Type
  • Biosample4657
    • Project
    Lab
    Sample Type
    4DN Cell Line Tier
    Biosource
    Organism
    Modifications
    Treatments
    Status
    Commendations
    Warnings
    4657 Results
    Title
    Organism
    Biosource
    Sample Type
    Modifications
    Treatments
    4DNBSNMKHQM6
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    dTAGv-1 treatment (500 nM, 24h)
    4DNBS54XWZHW
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    dTAGv-1 treatment (500 nM, 24h)
    4DNBS5PDJ4VW
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    dTAGv-1 treatment (500 nM, 24h)
    4DNBS4LQ2849
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    DMSO treatment (24.0h)
    4DNBSJJASAQ6
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    DMSO treatment (24.0h)
    4DNBS81FYJTK
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    DMSO treatment (24.0h)
    4DNBSDRMFC66
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    dTAGv-1 treatment (500 nM, 24h)
    4DNBSME7GN9M
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    dTAGv-1 treatment (500 nM, 24h)
    4DNBSIS842HG
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    DMSO treatment (24.0h)
    4DNBSL5Z2AXN
    human
    dTAG-TBX5 iPSC line differentiated to cardiac muscle cell
    in vitro differentiated cells
    -
    DMSO treatment (24.0h)
    4DNBS41SB8HA
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    -
    4DNBSRYAON19
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    -
    4DNBS2WY1RLF
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    Triptolide (T3652, Millipore-Sigma) treatment (0.1 μg/mL, 4.0h at 37.0°C)
    4DNBS5HEEGDV
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    Triptolide (T3652, Millipore-Sigma) treatment (0.1 μg/mL, 4.0h at 37.0°C)
    4DNBSYRCA5ZI
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    DRB (D1916, Millipore-Sigma) treatment (50.0 μg/mL, 4.0h at 37.0°C)
    4DNBSGV21PKS
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    DMSO (D2650, Millipore-Sigma) treatment (0.01 percent, 4.0h at 37.0°C)
    4DNBS6GQN3A3
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    DMSO (D2650, Millipore-Sigma) treatment (0.01 percent, 4.0h at 37.0°C)
    4DNBSEG8597H
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    -
    4DNBSQWSXVOC
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    Triptolide (T3652, Millipore-Sigma) treatment (0.1 μg/mL, 4.0h at 37.0°C)
    4DNBSIP4IZY6
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    Triptolide (T3652, Millipore-Sigma) treatment (0.1 μg/mL, 4.0h at 37.0°C)
    4DNBS7OVN7QY
    human
    RPE-hTERT (Tier 2)
    immortalized cells
    -
    DRB (D1916, Millipore-Sigma) treatment (50.0 μg/mL, 4.0h at 37.0°C)
    4DNBSJR1BPPV
    mouse
    NIH3T3
    immortalized cells
    -
    -
    4DNBS4C1181X
    mouse
    NIH3T3
    immortalized cells
    -
    -
    4DNBSMFR3DPO
    mouse
    NIH3T3
    immortalized cells
    -
    -
    4DNBSVLWC2F1
    mouse
    NIH3T3
    immortalized cells
    -
    -